Literature DB >> 7259347

Clinical and secretory differences in pancreatic cancer and chronic pancreatitis.

R L Goodale, R M Condie, K Gajl-Peczalska, T Taylor, J O'Leary, T Dressel, J W Borner, M P Frick, D S Fryd.   

Abstract

The differential diagnosis between chronic pancreatitis and pancreatic cancer can be very difficult. In 60 patients with either of these conditions, who had satisfactory ERCP study, clinical features were correctly matched with the final diagnosis by discriminant analysis in 44 (73%). The sensitivity of ERCP radiographic findings in pancreatic cancer was 80% and sensitivity of cytology was 54%. To see if exocrine function was specific for cancer, fresh pancreatic secretions were aspirated in 27 patients at the time of ERCP. By isoelectric focusing, a pattern of extreme zymogen depletion was observed in chronic alcoholic pancreatitis (Group 1), pancreatic cancer (Group 2), and chronic nonalcoholic pancreatitis (Group 3). The three groups were not distinguishable. By contrast, significant changes in albumin, IgG and IgA concentrations were seen in Group 2. The albumin level was over ten-fold greater than in Groups 1 and 3 (p less than 0.02 and less than 0.05). The IgG was seven-fold and two-fold greater (p less than 0.01 and greater than 0.2) and the IgA was 15-fold and six-fold greater (p less than 0.002 and less than 0.05) than in Groups 1 and 3, respectively. The two groups of pancreatitis had similar concentrations of albumin and IgA. The ratio of albumin to IgG was also different in Group 2 from the other groups, suggesting different mechanisms for the appearance of proteins in pancreatic secretions. Nonzymogen protein levels can distinguish chronic pancreatitis from pancreatic cancer, and further study of them may identify useful tumor-specific markers.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7259347      PMCID: PMC1345240          DOI: 10.1097/00000658-198108000-00014

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  25 in total

1.  The laboratory diagnosis of pancreatic disease: secretin test.

Authors:  D A DREILING; H D JANOWITZ
Journal:  Am J Gastroenterol       Date:  1957-09       Impact factor: 10.864

2.  Pancreatitis associated with pancreatic carcinoma: a study of 26 cases.

Authors:  E E Gambill
Journal:  Mayo Clin Proc       Date:  1971-03       Impact factor: 7.616

3.  The interrelationships of pancreatic enzymes in health and diseases under cholecystokinin stimulation.

Authors:  Y Minaire; L Descos; J P Daly; M B Bererd; R Lambert
Journal:  Digestion       Date:  1973       Impact factor: 3.216

4.  Cholangiopancreatography and pancreatic cytology in carcinoma of the pancreas.

Authors:  R A Wilkins; A Hatfield
Journal:  AJR Am J Roentgenol       Date:  1977-05       Impact factor: 3.959

5.  Secretion of pancreatic enzymes. I. Response to secretin and pancreozymin.

Authors:  L Zieve; S E Silvis; B Mulford; W D Blackwood
Journal:  Am J Dig Dis       Date:  1966-09

6.  Pancreatic carcinoma. Survival following detection by ultrasonic scanning.

Authors:  L R McCormack; S G Seat; W B Strum
Journal:  JAMA       Date:  1977-07-18       Impact factor: 56.272

7.  Pancreatic acinar cell metabolism and function.

Authors:  P D Webster; O Black; D L Mainz; M Singh
Journal:  Gastroenterology       Date:  1977-12       Impact factor: 22.682

8.  Cytologic studies for the diagnosis of pancreatic cancer.

Authors:  R L Goodale; K Gajl-Peczalska; T Dressel; J Samuelson
Journal:  Cancer       Date:  1981-03-15       Impact factor: 6.860

9.  Endoscopic retrograde cholangiopancreatography (ERCP) in pancreatic disease: a reassessment of the specificity of ductal abnormalities indifferentiating benign from malignant disease.

Authors:  P W Ralls; J Halls; I Renner; H Juttner
Journal:  Radiology       Date:  1980-02       Impact factor: 11.105

10.  The relationships between pancreatic ductal obstruction and pancreatic secretion in man.

Authors:  E P DiMagno; J R Malagelada; V L Go
Journal:  Mayo Clin Proc       Date:  1979-03       Impact factor: 7.616

View more
  6 in total

1.  Secretory immunoglobulin A in pancreatic juice and pancreatic tissue of patients with chronic pancreatitis.

Authors:  J Emmrich; M Seyfarth; P Conradi; F Plath; G Sparmann; M Löhr; S Liebe
Journal:  Gut       Date:  1998-03       Impact factor: 23.059

2.  Accuracy of endoscopic retrograde cholangiopancreatography (ERCP) in differentiating benign and malignant pancreatic disease.

Authors:  M P Frick; J F O'Leary; H C Walker; R L Goodale
Journal:  Gastrointest Radiol       Date:  1982

3.  Human pancreatic secretory protein profiles in pancreas cancer and chronic pancreatitis.

Authors:  T T White; B J Allan; J J Schilling; H Miyashita
Journal:  Dig Dis Sci       Date:  1985-03       Impact factor: 3.199

Review 4.  Carcinoma of the head of the pancreas versus chronic pancreatitis: diagnostic dilemma with significant consequences.

Authors:  Bryce Taylor
Journal:  World J Surg       Date:  2003-10-13       Impact factor: 3.352

5.  Human pancreatic secretory protein profiles in the search for tumor markers.

Authors:  T T White; B J Allan; J J Schilling; H Miyashita
Journal:  Dig Dis Sci       Date:  1983-09       Impact factor: 3.199

6.  Analysis of pure pancreatic juice proteins by two-dimensional gel electrophoresis in cases of pancreatic cancer.

Authors:  J Satoh; V M Darley-Usmar; H Kashimura; H Fukutomi; K Anan; T Ohsuga
Journal:  Gastroenterol Jpn       Date:  1986-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.